A drug used to treat glaucoma may protect against tau protein buildup in the brain, a key marker of dementias such as ...

As an international competition that places a premium on creative thinking and the development of a research community of all ages, iGEM is helping synthetic biology grow. Imagine a generic cure ...

A class of proteins containing domains that are evolutionarily conserved among prokaryotes and eukaryotes was recently found to mediate post-translational AMP addition—a new protein modification ...

New research into a chemical from a caterpillar fungus, known for its potential as a cancer treatment, has shown how it interacts with genes to disrupt cell growth signals. This finding marks a ...

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of ...

By Dr. Chinta Sidharthan Carbonic anhydrase inhibitors show promise in reducing tau protein buildup and neurodegeneration, paving the way for new treatments in neurodegenerative diseases. Study: ...

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

A common drug used to treat glaucoma has shown promise for neurodegenerative disease. The drug was able to prevent the ...

A team led by Prof. Wang Chao and Prof. Huang Chengdong from the University of Science and Technology of China (USTC) of the ...

The tau build up was also cleared in mice with the P301S human disease-causing mutation, which can lead to Alzheimer's, ...